Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the meeting or topic
Accelerate the Creation of Best-in-Class Platforms for Next-Generation Modalities by Leveraging AI & State-of-the Art Drug Discovery Technologies
South Korea is establishing itself as a distinct drug discovery innovation ecosystem. Fueled by significant government investment and recent partnerships involving companies such as HK Inno.N, Atomatrix, OliX, Galux, Samsung Bioepis, SK Biopharmaceuicals, Dong-A ST and Celltrion, K-Bio is increasingly making headlines through its dedication to integrate AI for smarter, faster and de-risked drug discovery and best-in-class potential platforms.
Built from the ground-up with in-depth market research from senior and expert K-Bio leaders, the World Novel Drug Discovery Summit South Korea is the first forum of its kind bringing together local and international industry leaders to shape Korea’s future as a global drug discovery powerhouse.
Uniting 100+ leaders from Eli Lilly, Sanofi, Hanmi Pharmaceuticals, Portrai, ONCOCROSS, Innovent Biologics and more, this is the unmissable forum for K-Bio and Asian drug discovery enthusiasts to accelerate the development of best-in-class potential platforms and be positioned for global partnership and out licensing opportunities through:
- Cutting-edge case studies of biologic and small molecule modality discovery
- Development and experimental validation of breakthrough AI/ML platform technologies
- International perspectives on proven drug discovery strategies
- Collaborative structured and spontaneous networking opportunities
Unmissable Event Highlights
놓칠 수 없는 행사 하이라이트
Global Discovery Leaders Panel Discussion
Hear from Korean and international discovery leaders Eli Lilly, Hanmi Pharm and KIT on the state-of-play of AI/ML in drug discovery, areas of promise and bottlenecks, and strategies to foster global collaborations
Industry-Leading Platform Showcases
Discover insights from leading discovery platform innovators like AIGENDRUG, Degron Tx, Portrai and ONCOCROSS, blending technical and strategic insights with experimental validation to unlock best-in-class discovery
Next-Generation Modality Case Studies
Access modality-agnostic discovery insights with content split evenly across biologics and small molecules including up and comping modalities ADCs, induced proximity and molecular glues, peptides and vaccines
AI/ML De Novo Discovery Workshop
Deep dive into of AI/ML and in silico model training, applications, validation, limitations and iterative DBTL workflows with AIGEN Sciences, Korea University and Seoul National University
Explore the Agenda
Hear the latest discovery innovations taking place within South Korea as well as perspectives from global experts.
Partner With Us
Position yourself to ensure your company is seen as the go-to discovery service provider for Korean drug developers.
Join Biopharma Experts
Be part of the technical and strategic conversations with 100+ drug discovery enthusiasts and decision makers.